Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Dehydroepiandrosterone and Nitric Oxide

Research Papers that Mention the Interaction

DHEA in vitro significantly promotes NO synthesis, suppresses MDA and MCP-1 secretion of endothelial cells, and decreases ICAM-1, VCAM-1 and E-selectin expression in HUVECs; neither selective ERα antagonist (methyl-piperidino-pyrazole, MPP) nor ERβ antagonist (R,R-tetrahydrochrysene, R,RTHC) can abolish these effects.
Atherosclerosis  •  2011  |  View Paper
In addition, recent studies in vitro have shown that DHEA has the capacity to improve endothelial function by increasing nitric oxide ( NO ) synthesis.
Journal of endocrinological investigation  •  2005  |  View Paper
Albumin-conjugated DHEA also stimulated NO release, suggesting that DHEA stimulates eNOS by a plasma membrane-initiated signal.
These findings demonstrate that physiological concentrations of DHEA acutely increase NO release from intact vascular endothelial cells, by a plasma membrane-initiated mechanism.
Steroids  •  2004  |  View Paper
We show that DHEA administration to human endothelial cells triggers nitric oxide synthesis, due to enhanced expression and stabilization of endothelial nitric oxide synthase (eNOS).
Endocrinology  •  2003  |  View Paper
DHEA 1) prevented platelet aggregation by 40% compared to control, 2) increased NO production by 63%, 3) increased p-eNOS (phosphorylated endothelial nitric oxide synthase) levels, and 4) increased cGMP production.
In light of these precedents and considering that DHEA is able to increase the production of NO in cultured endothelial cells, we suggest that DHEA prevents the aggregation of platelet from postmenopausal women with T2D through the activation of PKC/eNOS/NO/cGMP pathway.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  •  2012  |  View Paper
Recently, it has been suggested that DHEAS can retard atherosclerosis formation through an increase in nitric oxide ( NO ) production by increasing E2 synthesis.
Journal of endocrinological investigation  •  2001  |  View Paper
In addition, DHEA improved the phagocytic ability, enhanced the NO production and increased the iNOS activity in peritoneal macrophages.
Molecular immunology  •  2019  |  View Paper
Zinc and DHEA supplementation exerted additive effects on the immune response by elevation of macrophage counts, and by increasing concentrations of IFN-gamma and NO.
Immunobiology  •  2010  |  View Paper
DHEA treatment promoted increased lymphoproliferative responses as well as enhanced concentrations of NO and IL-12.
Veterinary parasitology  •  2009  |  View Paper
DHEA treatment augments NO production for both sexes after in vitro LPS treatment for uninfected animals.
Veterinary parasitology  •  2008  |  View Paper
Show More